13th March 2026 In this webinar for the GENTURIS European Reference Network, Marc Tischkowitz gives an update on PALB2 and puts forward the argument for calling it BRCA3. Please click here to view this (you will need to register) Category: NewsPrevious Post:New study shows that PARP inhibitors are effective in PALB2-related breast cancer Next Post:Goodbye Breasts! An award-winning feature documentary by Joanna Callaghan.